04:42 PM EDT, 07/05/2024 (MT Newswires) -- Calidi Biotherapeutics ( CLDI ) said Friday its board approved a 1-for-10 reverse split of its shares.

The company said its shares will start trading on a split-adjusted basis July 15.

Shares of the company were down over 3% in after-hours trading.

Price: 0.1919, Change: -0.01, Percent Change: -3.28